human glp-1 Glucagon‐like peptide‐1: Are its roles as endogenous hormone and therapeutic wizard congruent? - Holst - 2022 - Journal of Internal Medicine GLP−1 Receptor Agonist Mechanisms GLP−1RAs

In dermatology, lower-dose regimens are not new

Lee J, Roh JL

Understanding your FTO and MC4R variants alongside GLP1R status may also illuminate metabolic baseline and satiety mechanism sensitivity

Effect of one weeks treatment with a GLP-1R Agonist on glycemia and HGP Diabetes, 53:1187;2004 Postprandial metabolism in T2DM with and without DPP-4 inhibition K Azuma, JCEM 2008 Islet cell response to hypoglycemia with and without DPP-4 inhibition Glucagon Vlda 47 ng/L Cntl 34 ng/L ISR Vlda -70 pmol/m2/min Cntl -62 pmol/m2/min PP Vlda 115 pmol/L Cntl 62 pmol/L B Ahren, JCEM 2009 Treatment with Exenatide does not impair the counterregulatory glucagon response Diabetes 53:2397;2004

In Your Gut GLP-1 slows intestinal absorption, helping injected insulins delayed response better match digestion and improve your after-meal readings